Baylor Scott & White Research Institute
A Phase III Clinical Trial to Study the Safety and Efficacy of MK-1293 Compared to Lantus™ in Subjects with Type 2 Diabetes Mellitus
Baylor Scott & White Research Institute
A Randomized, Multicenter Study to Evaluate Cardiovascular Outcomes with ITCA 650 in Patients Treated with Standard of Care for Type 2 Diabetes
Baylor Scott & White Research Institute
A trial comparing cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.
Research Center
FIDELIO-DKD & FIGARO-DKD – For Patients with Type 2 Diabetes
View More »
Research Site
A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease
Research Site
A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease
Research Site
A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease
Research Site
A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease
Research Site
A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease
Research Site
Patients are needed to participate in a clinical research study evaluating Welchol for oral suspension placebo proxy and Welchol for oral suspension for the treatment of Type 2 Diabetes Mellitus
Research Site
A Phase 2 clinical study for patients with Type 2 Diabetes Mellitus
Research Site
A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease
Baylor Endocrine Center
A Phase 3 clinical study for patients with Type 2 Diabetes or Comparative Effectiveness of Glycemia-lowering Medications
Dallas Diabetes & Endocrine Center
Patients are needed to participate in a clinical research study evaluating BFKB8488A and Placebo for the treatment of Diabetes Mellitus, Type 2
Dallas Diabetes Endocrine Center Updated
Patients are needed to participate in a clinical research study of LY3298176, Dulaglutide and Placebo to evaluate Type 2 Diabetes Mellitus
Dallas Diabetes Endocrine Center
Patients are needed to participate in a clinical research study of Dulaglutide and Placebo to evaluate Type 2 Diabetes
Investigational Site Number 8400001 Updated
A clinical research study for the treatment of Type 2 Diabetes Mellitus
Investigational Site Number 840011 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Investigational Site Number 840013 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Investigational Site Number 840034 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Investigational Site Number 8402030 Updated
Patients are needed to participate in a clinical research study of Sotagliflozin (SAR439954), Placebo and Metformin to evaluate Type 2 Diabetes Mellitus
Investigational Site Number 8403002 Updated
A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus
Investigational Site Number 840313 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Investigational Site Number 840333 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Investigational Site Number 840405 Updated
Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)
Novo Nordisk Investigational Site
A Phase 3 clinical study for patients with Metabolism and Nutrition Disorder or Obesity
Novo Nordisk Investigational Site Updated
Patients are needed to participate in a clinical research study evaluating Semaglutide, Canagliflozin, Canagliflozin placebo and Semaglutide placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical trial seeking patients for a research study for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site
A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
Patients are needed to participate in a clinical research study evaluating Semaglutide, Canagliflozin, Canagliflozin placebo and Semaglutide placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical trial to evaluate treatments using Semaglutide and Placebo for patients with Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site
A Phase 3 clinical study for patients with Metabolism and Nutrition Disorder or Obesity
Novo Nordisk Investigational Site Updated
A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
Patients are needed to participate in a clinical research study evaluating Semaglutide, Canagliflozin, Canagliflozin placebo and Semaglutide placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical trial to evaluate treatments using Semaglutide and Placebo for patients with Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site
A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical trial seeking patients for a research study for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site
A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical research study of semaglutide and placebo for the treatment of Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2
Novo Nordisk Investigational Site Updated
A clinical trial to evaluate treatments using semaglutide and placebo for patients with Diabetes or Diabetes Mellitus, Type 2
Parkland Memorial Hospital
Patients are needed to participate in a clinical research study of Levemir (Detemir) and Novolog (Aspart) Insulin to evaluate Type 2 Diabetes
Research Institute of Dallas
Patients are needed to participate in a clinical research study of ITCA 650 20/60 mcg/day, Empagliflozin (oral) and Glimepiride (oral) to evaluate Diabetes Mellitus, Type 2
Research Site
Patients are needed to participate in a clinical research study evaluating Exenatide Once Weekly and Placebo for the treatment of Children and Adolescent With Type 2 Diabetes
Research Site
Patients are needed to participate in a clinical research study evaluating placebo and exenatide for the treatment of Type 2 Diabetes
University of Texas-Southwestern Medical Center
A Phase 3 clinical study for patients with Type 2 Diabetes or Comparative Effectiveness of Glycemia-lowering Medications